Professional Documents
Culture Documents
competitive
Drug Binding
groups
Pharmacological
2. Drug-Receptor interaction response Intermolecular
bonds
A receptor is the specific chemical constituents of the cell with which a drug
interacts to produce its pharmacological effects
This is usually through specific drug receptor sites known to be located on the Binding site
membrane
Binding Drug
site
Drug
3. Non-specific interactions
Drugs act exclusively by physical means outside of cells
These sites include external surfaces of skin and gastrointestinal tract.
Macromolecular target Macromolecular target
Drugs also act outside of cell membranes by chemical interactions
Neutralization of stomach acid by antacids is a good example
Unbound drug Bound drug
3 4
An Introduction to Medicinal Chemistry, Patrick, Third Edition
Mechanisms of Actions of Drugs
Drug-Receptor Interactions
3. Chemical Properties
vdw
interaction
• The drugs react extracellularly according to simple
chemical reactions like neutralization, chelation, oxidation
Drug
H-bond etc.
Active site
H ionic
Phe
Aluminium hydroxide neutralizes acid in stomach
O
bond
Ser
CO2
Asp
Toxic heavy metals can be eliminated by chelating agents
like EDTA, BAL, penicillamine etc.
receptor
• Receptors/enzymes are proteins, so they are amino acids (Asp, Phe, Ser)
• amino acids contain:
carboxylic acids (ionic interaction)
amines (ionic interaction)
hydroxyl (hydrogen bond) 5 6
An Introduction to Medicinal Chemistry, Patrick, Third Edition
Functional Groups and Pharmacological Activity Physiochemical Properties – Acids & Bases
(Agonist, Antagonists)
The human body is composed of ~75% water (55 L of water)
If acetylcholine interacts with its receptor, then molecules that are For an average drug (MW ~200; dose = 20 mg), this equates to a drug
structurally similar to acetylcholine would also interact with the receptor concentration of ~1.8 x 10-6M (i.e. a very dilute solution!)
acetylcholine "antagonist" For dilute solutions we use the Brönsted–Lowry theory to predict the
behaviors of acids & bases
• Antagonists are An Acid is any substance capable of yielding a proton (H+)
generally larger in
size than the A base is any substance capable of accepting a proton (H+)
natural substrate
CH3COOH + H 2O CH3COO + H 3O
acetylcholine + receptor acetylcholine blocked
from receptor acid base conjugate conjugate
base acid
This is sort of a “lock & key” approach, wherein if you stop acetylcholine
from binding to its receptor (by using another molecule that is similar in CH3NH2 + H 2O CH3NH3 + HO
structure) then you will stop the effect of acetylcholine conjugate conjugate
base acid
acid base
i.e. acetylcholine causes muscles to contract, if you stop it from binding Please refer to Table 2.1 (pg. 29, Foye), Table 2.2 (pg. 30, Foye), and Table 2.3
to its receptor, muscles will therefore relax 7 (pg. 30, Foye) 8
Physiochemical Properties – Acids & Bases Relative Acid Strength (pKa)
Some drugs have both acidic and basic functional groups, and therefore can act as (Henderson–Hassalbach)
a base, an acid, or amphoteric (= both acidic & basic properties)
neutral
Henderson-Hasselbach Equation relates pH and pKa (acid strength)
Ciprofloxacin
The location of the compound in the body will determine the overall charge since pKa is a constant for a given molecule, at a known pH (e.g.
of the compound physiological) the concentration of the acidic and basic forms of a given drug
will be able to be calculated
O O O
F CO2H F
O But why is this important??
H
N N
H
N N percent ionisation (clue to absorption of drug and activity/interactions)
N N
H H
9 10
stomach (pH 1.0 to 3.0) Duodenum (pH ~ 4)
O
H R= 6.4 26 140 17 These compounds are only active in their ionised forms
N
sulfadiazine
Despite only minor differences in half-life and lipo-solubility, there is a huge difference H2N O H2N S N R
in activity O
PABA sulfonamide
This is due to their respective pKa values:
O
For sulfadiazine, at pH 7.4 it is ~80% ionised O
For sulfanilamide, at pH 7.4 it is only 0.03% ionised
H2N H2N S NHR
O O
The difference in pKa is due to the electron withdrawing nature of the sulfonamide H-bond v.d.w. H-bond v.d.w.
nitrogen substituent, thereby stabilising the ionised form: ionic ionic
17 18
ketone R R' 5 to 6 carbons 2 carbons We get a total “solubilising potential” of 9 carbons using this theory.
amine R NH2 6 to 7 carbons 3 carbons
Since the molecule contains 22 carbons, it suggests that the molecule is insoluble
carboxylic acid 5 to 6 carbons 3 carbons in water (USP has water solubility listed as <1g per 10,000ml)
O
ester (R' = OR) 6 carbons 2 to 3 carbons However, if we make the hydrochloride salt, then the compound becomes water
amide (R' = NHR)
R R'
6 carbons 2 carbons
soluble
Lemke estimates that a charge (either anionic or cationic) contributes a
Given that most drugs are polyfunctional, the second column is most relevant 19 “solubilising potential” of between 20 and 30 carbons 20
C (aliphatic) + 0.5 C (aliphatic) + 0.5
Phenyl + 2.0 Phenyl + 2.0
Cl + 0.5 Cl + 0.5
S +0 S +0
O (hydroxyl, ether) – 1.0 O (hydroxyl, ether) – 1.0
N (amine) – 1.0 N (amine) – 1.0
IMHB + 0.65 IMHB + 0.65
O=C–O (carboxyl) – 0.7 O=C–O (carboxyl) – 0.7
21 22
O=C–N (amide) – 0.7 O=C–N (amide) – 0.7